Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6295)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi BM, Lu W, Ji K, Wang YF, Xiao S, Wang XY. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3713-3720 [PMID: 28611524 DOI: 10.3748/wjg.v23.i20.3713] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i20/3713.htm |
| Number | Citing Articles |
| 1 |
Hamdy E.A. Ali, Ahmed A. Emam, Ahmed A. Zeeneldin, Reham Srour, Reda Tabashy, Eman D. El-Desouky, Zakaria Y. Abd Elmageed, Abdel-Hady A. Abdel-Wahab. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization. Clinical Biochemistry 2019; 65: 45 doi: 10.1016/j.clinbiochem.2019.01.002
|
| 2 |
Farzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, Angelo Sangiovanni, Paola Guerriero, Giuseppina De Petro, Cristian Bassi, Laura Lupini, Arash Sattari, Douglas Cheung, Dario Veneziano, Giovanni Nigita, Ram C. Shankaraiah, Nazario Portolani, Paolo Carcoforo, Francesca Fornari, Luigi Bolondi, Antonio Frassoldati, Silvia Sabbioni, Massimo Colombo, Carlo M. Croce, Massimo Negrini. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget 2018; 9(20): 15350 doi: 10.18632/oncotarget.24601
|
| 3 |
Long Chen, Yu Chen, Yuan-Ling Feng, Yan Zhu, Li-Quan Wang, Shen Hu, Pu Cheng. Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis. World Journal of Clinical Cases 2020; 8(11): 2066-2080 doi: 10.12998/wjcc.v8.i11.2066
|
| 4 |
Yi Shi, Jingrui Men, Hongliang Sun, Jianjun Tan. The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 2022; 18(10): 1073 doi: 10.2174/1573406418666220404084532
|
| 5 |
Fen Hu, Yonglian Wang, Xueqing Wu, Shan Liu, Haiying Ren, Wenhui Zhou. RETRACTED: Overexpressed miR-106b-5p promotes epithelial-mesenchymal transition in endometriosis by targeting PTEN. Reproductive Toxicology 2022; 113: 62 doi: 10.1016/j.reprotox.2022.07.007
|
| 6 |
Long Liu, Qi Wang, Linjun Wu, Lele Zhang, Yuxi Huang, Haihua Yang, Le guo, Zheping Fang, Xuequan Wang. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02949-z
|
| 7 |
José Debes, Pablo Romagnoli, Jhon Prieto, Marco Arrese, Angelo Mattos, André Boonstra. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma. Cancers 2021; 13(7): 1681 doi: 10.3390/cancers13071681
|
| 8 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 9 |
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World Journal of Gastroenterology 2019; 25(29): 4199 doi: 10.3748/wjg.v25.i29.4199
|
| 10 |
Surendra Kumar Sagar. miR-106b as an emerging therapeutic target in cancer. Genes & Diseases 2022; 9(4): 889 doi: 10.1016/j.gendis.2021.02.002
|
| 11 |
Qi Zhou, Weicai Ye, Xiaolan Yu, Yun-Juan Bao. A pathway-based computational framework for identification of a new modal of multi-omics biomarkers and its application in esophageal cancer. Computer Methods and Programs in Biomedicine 2024; 247: 108077 doi: 10.1016/j.cmpb.2024.108077
|
| 12 |
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World Journal of Gastroenterology 2019; 25(30): 4199-4212 doi: 10.3748/wjg.v25.i30.4199
|
| 13 |
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?. Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
|
| 14 |
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
|
| 15 |
Xiaojing Li, Xianpeng Zeng. Shikonin suppresses progression and epithelial–mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR‐106b/SMAD7/TGF‐β signaling pathway. Cell Biology International 2020; 44(2): 467 doi: 10.1002/cbin.11247
|